Evidence map›Paper›PMID 23986634›Full record

ReviewInternational journal of nanomedicine2013

Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations.

Eder Lilia Romero, Maria Jose Morilla

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Transfersomal eosin topical delivery assisted by fractional CODrug delivery and translational research · 2022
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Use of Nanoparticles in Delivery of Nucleic Acids for Melanoma Treatment.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  20. Lipid-based nanoparticles in the treatment of erectile dysfunction.International journal of impotence research · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Eder Lilia RomeroDepartment of Science and Technology, National University of Quilmes, Bernal, Buenos Aires, Argentina. elromero@unq.edu.ar
Maria Jose Morilla

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vesicles that are specifically designed to overcome the stratum corneum barrier in intact skin provide an efficient transdermal (systemic or local) drug delivery system. They can be classified into two main groups according to the mechanisms underlying their skin interaction. The first group comprises those possessing highly deformable bilayers, achieved by incorporating edge activators to the bilayers or by mixing with certain hydrophilic solutes. The vesicles of this group act as drug carriers that penetrate across hydrophilic pathways of the intact skin. The second group comprises those possessing highly fluid bilayers, owing to the presence of permeation enhancers. The vesicles of this group can act as carriers of drugs that permeate the skin after the barrier of the stratum corneum is altered because of synergistic action with the permeation enhancers contained in the vesicle structure. We have included a detailed overview of the different mechanisms of skin interaction and discussed the most promising preclinical applications of the last five years of Transfersomes® (IDEA AG, Munich, Germany), ethosomes, and invasomes as carriers of antitumoral and anti-inflammatory drugs applied by the topical route.

Indexed as

Administration, TopicalDrug CarriersLiposomesAnimalsAnti-Inflammatory AgentsAntineoplastic AgentsCell LineHumansMiceRatsSkin AbsorptionAnti-Inflammatory AgentsAntineoplastic AgentsDrug CarriersLiposomesanti-inflammatoryantitumoralethosomestopical deliveryTransfersomes

Identifiers

PMID23986634
PMCPMC3754763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.